- Home
- A-Z Publications
- Mini Reviews in Medicinal Chemistry
- Previous Issues
- Volume 12, Issue 14, 2012
Mini Reviews in Medicinal Chemistry - Volume 12, Issue 14, 2012
Volume 12, Issue 14, 2012
-
-
Carbohydrate Mimics and Lectins: A Source of New Drugs and Therapeutic Opportunities
Authors: Jose J. Reina and Anna BernardiMimics of oligosaccharides capable of interfering with lectin activity are currently being pursued by a number of groups in an effort to produce tools for glycobiology and to design antagonists of medically relevant lectins. The field is reviewed in this chapter. After a brief overview of the state of the art, examples from our and others' studies on the dendritic cell receptor DC-SIGN are illustrated.
-
-
-
A Short Overview on the Medicinal Chemistry of (—)-Shikimic Acid
Authors: Amalia M. Estevez and Ramon J. EstevezShikimic acid, a natural compound is a key intermediate in the biosynthesis of amino acids. Consequently, this derivative is widely present in many plants and has interesting biological properties. But besides the pharmacological relevance of shikimic acid itself, it is also an intermediate in the synthesis of many drugs, being the most relevant the antiviral agent oseltamivir (TamifluTM). Here we present a short overview on rece Read More
-
-
-
Recent Progress on Fucosyltransferase Inhibitors
Fucosyltransferases (FucTs) are enzymes that transfer L-fucose from GDP-fucose to a glycoside or a peptide. They have important roles in a variety of diseases including cancer and autoimmune disorders, viral and bacterial infections and inflammatory processes, and thus they represent important drug targets for the development of agents for the treatment of such disorders. This review highlights recent developments r Read More
-
-
-
Diels-Alder Cycloaddition in the Synthesis of 1-Azafagomine, Analogs, and Derivatives as Glycosidase Inhibitors
Authors: Daniela A.L. Salgueiro, Cristina E.A. Sousa, A. Gil Fortes and M. Jose AlvesThis comprehensive review deals with the synthesis of 1-azafagomine, analogs, and derivatives having the Diels-Alder cycloaddition as the key step. Most of the compounds referred are racemic or have been resolved by lipase transesterification. There are two asymmetric cycloadditions leading to 1-azafagomine or to an analog. In one case both enantiomers of 1-azafagomine were prepared together with a pair of derivatives. Th Read More
-
-
-
Advances in the Synthesis of Calystegines and Related Products and their Biochemical Properties
Authors: M.S. Pino-Gonzalez, N. Ona and A. Romero-CarrascoThe revision of the structures and properties of Calystegines shows that they can be regarded as carbohydrate mimics, with related biological activities and peculiar characteristics. Not only they can be isolated from food plants, but they can be obtained from a variety of monosaccharide derivatives and of non-carbohydrate products. Although several synthetic calystegine analogs have been reported as glycosidase inhibit Read More
-
-
-
Spirocyclic Nucleosides in Medicinal Chemistry: An Overview
Authors: Raquel G. Soengas and Sandrina SilvaThis review describes some spiro- and pseudospironucleoside derivatives as well as their biological and pharmacological applications.
-
-
-
Carbohydrate based Potential Chemotherapeutic Agents: Recent Developments and their Scope in Future Drug Discovery
Authors: Vinod K. Tiwari, Ram C. Mishra, Anindra Sharma and Rama P. TripathiIn addition to being valuable source of energy, carbohydrates, one of the main dietary components, are integral parts of the cell. As extra- & intracellular molecules they act as cell surface receptor and also as signaling molecules playing predominant role in molecular recognition and many other cellular processes. The clear understanding of their role in the various important biological events has led to the demand for Read More
-
-
-
Mycalamides, Pederin and Psymberin as Natural Carbohydrates and Potential Antitumor Agents: Past and Future Perspectives
Authors: Zbigniew J. Witczak, Ricky M. Rampulla and Ajay BommareddyThe mycalamide class of potent antiviral and antitumor natural compounds originally isolated from marine sponges in 1988 is a new interdisciplinary approach to molecular recognition. We review new synthetic approaches to this new family of natural products with remarkable biological activity. Some biological evaluation data are compiled and compared to other structurally similar molecular targets.
-
-
-
Development of Aminoglycoside Antibiotics by Carbohydrate Chemistry
Authors: Lina Guo, Yue Wan, Xin Wang, Peng George Wang and Wei ZhaoWith the development of glycomics, more and more carbohydrate mimetics were used to investigate the interactions between carbohydrate-proteins, especially in physiological and pathological processes, molecular recognition, signal transduction, cell communication, cell differentiation and developmental events. Recently, because of the drugresistance of microorganisms and the development of antibiotics, the interacti Read More
-
-
-
Pharmacophore Development and SAR Studies of Imidazoline Receptor Ligands
Authors: Katarina Nikolic and Danica AgbabaRelationship between biological responses and binding affinities at I1/I2/I3 imidazoline receptors of compounds with imidazoline, pyrroline or oxazoline moieties was studied by 2D-QSAR, 3D-QSAR and quantitative pharmacophore development approaches. Since the I1 imidazoline receptor is involved in central inhibition of sympathicus that produce hypotensive effect, the I2 receptor is allosteric modulator of mono Read More
-
-
-
Plausible Improvements for Selective Targeting of Dopamine Receptors in Therapy of Parkinson's Disease
Authors: Pratibha Mehta Luthra and J.B. Senthil KumarParkinson's disease (PD) is a neurodegenerative condition characterized by progressive and profound loss of dopaminergic neurons in the substantia nigra pars compacta leading to the formation of eosinophillic, intracytoplamic, proteinacious inclusions termed as lewy bodies. L-dopa remains as a gold standard for the treatment of PD, and is often combined with carbidopa to reduce the dose-limiting side effects. Long- Read More
-
Volumes & issues
-
Volume 25 (2025)
-
Volume 24 (2024)
-
Volume 23 (2023)
-
Volume 22 (2022)
-
Volume 21 (2021)
-
Volume 20 (2020)
-
Volume 19 (2019)
-
Volume 18 (2018)
-
Volume 17 (2017)
-
Volume 16 (2016)
-
Volume 15 (2015)
-
Volume 14 (2014)
-
Volume 13 (2013)
-
Volume 12 (2012)
-
Volume 11 (2011)
-
Volume 10 (2010)
-
Volume 9 (2009)
-
Volume 8 (2008)
-
Volume 7 (2007)
-
Volume 6 (2006)
-
Volume 5 (2005)
-
Volume 4 (2004)
-
Volume 3 (2003)
-
Volume 2 (2002)
-
Volume 1 (2001)
Most Read This Month
Article
content/journals/mrmc
Journal
10
5
false
en
